Headed to BIO in San Diego this June? Plan some time to meet with our complex biologics and bioconjugate experts while you’re there.  Our scientific and commercial leadership will be on hand in booth #5019, participating in the in-booth partnering and 1:1 partnering 360.

Whether you’re working through cell line development, optimizing your biologic’s developability, or looking for a fully integrated CDMO partner to de-risk your pipeline, our drug development experts are ready to dig into the science with you.  At Abzena, we believe that true integration matters. From candidate selection through IND-enabling studies, process development, analytical development and GMP manufacturing, our end-to-end capabilities mean your program moves faster — with a single team that knows your molecule at every stage.

Our attending team of drug development experts includes:

• Dr Campbell Bunce, CSO
• Gavin Murdoch, SVP of Commercial Strategy
• Barbara Arnold, Head of North America Business Development
• Jonathan Cruickshank, Head of EU & APAC Business Development
• Kimberly Burrell, SVP of Global Marketing
• John Gill, VP & Scientific Leader- Cell Line Development
• Dr Francisco Velázquez, Sr. Director of Chemistry
• Nana-Yaw Otieku, VP of Business Development
• Evan Wahl, Sr. Director, Business Management
• Kevin Ranke, Sr. Director of Business Development
• Parth Shah, Director of R&D Business Development

Let’s talk about what’s standing between your program and its next milestone. Schedule some time to speak with our team at BIO: